›The same 0.1 to 0.2 mg per kg intravenously, given slowly over 3 to 5 minutes
›Repeat once after 15 to 20 minutes if hyperpnea persists and perfusion allows
›Reduce the dose and slow the rate when hypotension or apnea is a concern
›Maximum single dose 15 mg
›Verify against current pediatric guideline before use
›Mechanism is central suppression of hyperpnea with sedation and reduced catecholamine drive
›Monitor respiratory rate and oxygen saturation and keep naloxone and airway equipment at the bedside
›Intranasal fentanyl when no line is present and rapid effect is wanted
›Fentanyl 1.5 to 2 micrograms per kg intranasally, split between the nostrils
›May repeat once at 10 minutes, maximum single dose 100 micrograms
›Verify against current pediatric guideline before use
›Avoids the crying and catecholamine surge of intravenous access
›Ketamine when sedation plus support of systemic vascular resistance is desirable
›Ketamine 0.5 to 1 mg per kg intravenously over 1 to 2 minutes
›Ketamine 3 to 4 mg per kg intramuscularly if there is no intravenous access
›Titrate further 0.25 to 0.5 mg per kg intravenous increments to effect
›Preserves airway reflexes and raises systemic vascular resistance, which reduces the shunt
›Maximum initial intravenous dose about 2 mg per kg
›Verify against current pediatric guideline before use
›Accept that any associated tachycardia can modestly worsen dynamic obstruction and combine with a beta blocker if needed
›Dexmedetomidine as a calming adjunct where available
›Dexmedetomidine 0.5 to 1 microgram per kg intravenously over 10 minutes then 0.2 to 0.7 micrograms per kg per hour
›Provides calm without respiratory depression and modestly slows the heart rate
›Pause the loading dose if bradycardia or hypotension develops
›Verify against current pediatric guideline before use
›Avoid sedatives that lower systemic vascular resistance without treating the spell
›Propofol 1 to 2 mg per kg intravenously drops systemic vascular resistance and can abruptly worsen the shunt
›If propofol is unavoidable for induction, pre-load with volume and start phenylephrine and use a reduced dose
Volume expansion and anaemia correction
›Isotonic crystalloid bolus to fill the right ventricular outflow tract
›Balanced crystalloid or 0.9 percent sodium chloride 10 to 20 mL per kg intravenously over 10 to 20 minutes
›Reassess after each aliquot and repeat to a total of 40 to 60 mL per kg while the liver stays small and work of breathing does not worsen
›Slow or stop if the liver edge descends or respiratory distress increases
›Increased preload widens the infundibulum and improves diastolic filling across the obstruction
›Verify against current pediatric guideline before use
›Isotonic maintenance fluid after the acute phase to prevent the dehydration that precipitates further spells
›Resume frequent small enteral feeds once the infant is stable
›Red cell transfusion to raise oxygen-carrying capacity
›Packed red blood cells 10 to 15 mL per kg intravenously over 3 to 4 hours when the haemoglobin is below about 150 g/l in a cyanotic infant
›Give 5 mL per kg aliquots with reassessment when heart failure or pulmonary overcirculation is a concern
›Correcting relative anaemia reduces spell frequency and severity
›Verify against current pediatric guideline before use
›Oral iron for iron deficiency once stable, ferrous sulfate providing 3 to 6 mg per kg per day of elemental iron divided once or twice daily
›Recheck haemoglobin and reticulocytes and continue iron for at least 3 months
›Sodium bicarbonate for a significant metabolic acidosis that is sustaining the hyperpneic cycle
›Sodium bicarbonate 1 to 2 mmol per kg intravenously over 10 to 30 minutes for a base deficit greater than 5 mmol/l or a pH below 7.2
›Recheck the blood gas 15 to 20 minutes after the dose and repeat guided by the base deficit
›Ensure effective ventilation first because bicarbonate generates carbon dioxide that must be exhaled
›Give as a dilute solution through a secure line and avoid extravasation
›Do not co-infuse with calcium-containing fluids
›Verify against current pediatric guideline before use
›Correcting acidaemia restores systemic vascular resistance responsiveness and reduces the central drive to hyperpnea
›Address the cause of the acidosis in parallel
›The definitive correction is restoring pulmonary blood flow, not repeated bicarbonate
›A persistent or worsening base deficit despite therapy signals a refractory spell that needs rescue
Systemic vascular resistance support
›Phenylephrine as the preferred vasoconstrictor
›Phenylephrine 5 to 10 micrograms per kg by intravenous bolus for an acute severe spell
›Follow with an infusion 0.1 to 0.5 micrograms per kg per minute titrated to saturation and perfusion
›Titrate up by 0.1 micrograms per kg per minute every 5 to 10 minutes to effect
›Step down in 0.1 micrograms per kg per minute decrements once the saturation stabilises to avoid rebound hypertension
›Usual maximum infusion about 3 to 5 micrograms per kg per minute
›Verify against current pediatric guideline before use
›Pharmacologic class is a selective alpha-1 agonist that raises systemic vascular resistance and reduces right-to-left shunting, with reflex slowing of the heart rate that also helps
›Norepinephrine as an alternative when one agent for both resistance and output is preferred
›Norepinephrine 0.05 to 0.1 micrograms per kg per minute intravenously, titrated to 0.5 micrograms per kg per minute
›Predominant alpha effect raises systemic vascular resistance with modest inotropy
›Verify against current pediatric guideline before use
›Do not use agents that lower systemic vascular resistance
›Dihydropyridine calcium channel blockers such as nicardipine and clevidipine are arterial vasodilators and are contraindicated in a spell
›Angiotensin converting enzyme inhibitors, hydralazine, and nitroprusside all deepen the shunt
Beta blockade for infundibular spasm
›Esmolol when a titratable intravenous agent is wanted
›Esmolol 500 micrograms per kg intravenously over 1 minute
›Followed by an infusion 50 micrograms per kg per minute
›Titrate by 25 to 50 micrograms per kg per minute every 5 to 10 minutes toward relief of the spell
›Move to smaller increments as the heart rate falls toward the low-normal range for age to avoid excessive negative inotropy
›Maximum 300 micrograms per kg per minute
›Omit the bolus and start the infusion at 25 to 50 micrograms per kg per minute if perfusion is borderline
›Verify against current pediatric guideline before use
›Relaxes the hypercontractile infundibulum and slows the heart rate to improve diastolic filling across the obstruction
›Propranolol when esmolol is unavailable
›Propranolol 0.01 to 0.1 mg per kg by slow intravenous injection over 5 to 10 minutes
›Start at 0.01 mg per kg and titrate upward, maximum single dose 1 mg in an infant and 3 mg in a child
›Repeat no more often than every 6 to 8 hours acutely
›Watch for bradycardia, hypotension, bronchospasm, and hypoglycaemia
›Verify against current pediatric guideline before use
›Oral propranolol 1 to 4 mg per kg per day divided every 6 hours as a bridge to repair once the acute spell settles
›Cautions common to beta blockade in a spell
›Avoid in overt cardiogenic shock or high-grade atrioventricular block
›Reserve for the spell not responding to positioning, oxygen, an opioid, volume, and phenylephrine
›Have atropine and a chronotropic backup available for excessive bradycardia
›Induction of general anaesthesia with a definitive airway
›Abolishes the catecholamine surge driving infundibular spasm and hyperpnea
›Preferred induction is ketamine 1 to 2 mg per kg with rocuronium 1 mg per kg for paralysis
›Etomidate 0.2 to 0.3 mg per kg is an alternative that better preserves systemic vascular resistance
›Pre-load with crystalloid and start phenylephrine before induction to blunt the fall in systemic vascular resistance
›Verify against current pediatric guideline before use
›Ventilate with a low mean airway pressure and 100 percent oxygen and avoid high positive end-expiratory pressure that impedes pulmonary blood flow
›Emergency catheterisation or surgery
›Balloon dilation or stenting of the right ventricular outflow tract or the duct to secure pulmonary blood flow
›Emergency systemic-to-pulmonary shunt or primary complete repair depending on anatomy and centre practice
›Extracorporeal membrane oxygenation
›Veno-arterial support as a bridge when spells recur despite maximal medical therapy or after arrest
›Manual and pharmacologic adjuncts while arranging rescue
›Manual abdominal compression or repositioning to further augment systemic vascular resistance
›Continue phenylephrine, beta blockade, volume, and bicarbonate titrated to the base deficit
Troubleshooting the spell that is not improving
›Re-examine the diagnosis
›Reconsider sepsis, supraventricular tachycardia, tension pneumothorax, foreign body aspiration, and methemoglobinemia
›Obtain focused echocardiography to confirm dynamic infundibular obstruction and exclude shunt or stent thrombosis
›Audit the interventions already delivered
›Confirm the infant is genuinely knee-to-chest and is not being over-handled
›Confirm a therapeutic opioid dose and an adequate cumulative fluid volume have been given
›Confirm the phenylephrine infusion is patent, connected, and reaching the patient
›Recheck and correct physiology
›Repeat blood gas, glucose, ionised calcium, haemoglobin, and lactate
›Treat glucose below 2.6 mmol/l with 10 percent dextrose 2 mL per kg intravenously
›Verify against current pediatric guideline before use
›Treat fever, correct a base deficit greater than 5 mmol/l, and transfuse if relatively anaemic
›Treat a precipitating infection
›Obtain blood culture then give empiric antibiotics when sepsis is the suspected trigger
›Neonate under 28 days: ampicillin 50 to 100 mg per kg per dose intravenously plus gentamicin 4 to 5 mg per kg intravenously, or ampicillin plus cefotaxime 50 mg per kg per dose
›Ampicillin monotherapy is inadequate at this age and a second agent for gram-negative and Listeria cover is required
›Avoid ceftriaxone in the neonate because it displaces bilirubin and precipitates with calcium
›Dosing interval varies with postnatal age and gestation, so confirm against a neonatal reference
›Infant 1 to 3 months: ceftriaxone 50 mg per kg per dose intravenously, with ampicillin added when Listeria is a concern
›Use meningitic dosing if a central nervous system source cannot be excluded
›Monitoring cadence during titrated therapy
›Continuous pulse oximetry and electrocardiogram with blood pressure every 3 to 5 minutes during active titration
›Blood gas every 15 to 20 minutes until the base deficit is clearly improving
›Reassess liver size and lung examination after every fluid aliquot
›Escalate on defined triggers
›No improvement within 15 to 30 minutes of full medical therapy
›A falling heart rate, a rising base deficit, or deteriorating mental status at any point
Iatrogenic harms to anticipate and avoid
›Intubation and positive pressure ventilation
›Induction agents and raised intrathoracic pressure drop systemic vascular resistance and pulmonary blood flow and can precipitate arrest
›Reserve for the refractory spell, pre-treat with volume and phenylephrine, and ventilate at a low mean airway pressure
›Sedation choices
›Propofol 1 to 2 mg per kg and high-dose benzodiazepine lower systemic vascular resistance and worsen the shunt
›Prefer ketamine, which supports systemic vascular resistance
›Fluid loading errors
›Under-resuscitation leaves the infundibulum empty and the spell unbroken
›Over-transfusion in a shunted infant with pulmonary overcirculation causes heart failure, so give in 5 mL per kg aliquots and reassess the liver
›Oxygen expectations
›Oxygen helps but will not correct the saturation, and chasing a normal number drives unnecessary escalation
›Inotropes and chronotropes are contraindicated during an active spell
›Dopamine, dobutamine, adrenaline, isoprenaline, and digoxin increase infundibular contractility and worsen dynamic outflow obstruction
›When a vasopressor is required use phenylephrine for its pure alpha-1 effect
›Adrenaline 0.01 mg per kg, which is 0.1 mL per kg of the 1 in 10000 concentration, intravenously is reserved for cardiac arrest only
›Verify against current pediatric guideline before use
›Vasodilators and afterload reduction
›Angiotensin converting enzyme inhibitors, hydralazine, nitroprusside, and dihydropyridine calcium channel blockers are contraindicated because lowering systemic vascular resistance increases right-to-left shunting
›Pulmonary vasodilators
›Inhaled nitric oxide and inhaled prostacyclin do not relieve a fixed or dynamic anatomic right ventricular outflow obstruction and waste time
›Prostaglandin E1 is not a spell treatment
›It has no role in a classic tetralogy spell that has antegrade pulmonary blood flow
›Alprostadil 0.01 to 0.05 micrograms per kg per minute intravenously is appropriate only for a duct-dependent lesion such as pulmonary atresia in a neonate
›Verify against current pediatric guideline before use
›Analgesia omission
›Leaving a distressed infant crying perpetuates the catecholamine-driven spell, so give opioid analgesia early
›Anticoagulation and fibrinolysis
›Not part of spell treatment, but systemic heparin or catheter-directed therapy is indicated for acute modified Blalock-Taussig-Thomas shunt thrombosis
›Weigh the bleeding risk from the erythrocytosis-associated coagulopathy
›Mechanical circulatory support
›An intra-aortic balloon pump has no role because diastolic augmentation does not address right ventricular outflow obstruction
›Veno-arterial extracorporeal membrane oxygenation is the correct mechanical support when it is needed